1. Home
  2. POWW vs LCTX Comparison

POWW vs LCTX Comparison

Compare POWW & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$2.22

Market Cap

252.9M

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.03

Market Cap

255.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWW
LCTX
Founded
1990
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
255.4M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
POWW
LCTX
Price
$2.22
$1.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.40
$6.25
AVG Volume (30 Days)
435.5K
978.6K
Earning Date
02-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
95.61
N/A
EPS
0.02
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$14.56
$109.40
Revenue Next Year
$0.50
N/A
P/E Ratio
$108.75
N/A
Revenue Growth
N/A
53.24
52 Week Low
$1.39
$1.00
52 Week High
$2.67
$2.09

Technical Indicators

Market Signals
Indicator
POWW
LCTX
Relative Strength Index (RSI) 54.63 40.52
Support Level $1.96 N/A
Resistance Level $2.46 $1.18
Average True Range (ATR) 0.05 0.05
MACD 0.01 -0.00
Stochastic Oscillator 92.59 12.50

Price Performance

Historical Comparison
POWW
LCTX

About POWW AMMO Inc.

Outdoor Holding Co the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketplace segment consists of the GunBroker e-commerce marketplace. The company generates the majority of its revenue from the Ammunition segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: